QQ客服 官方微博 反馈留言

	betablockers inhibit the viability of breast cancer cells by regulating the ERK/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms.
	Xie, Wan-Ying; He, Ruo-Hui; Zhang, Jun; He, Yi-Jing; Wan, Zan; Zhou, Cheng-Fang; Tang, Yong-Jun; Li, Zhi; Mcleod, Howard L; Liu, Jie
刊名	Oncology Reports
	2019
卷号	41期号:1页码:341-350
关键词	Mitogen-activated protein kinase signaling pathway Triple-negative breast cancer β 2 -adrenergic receptor single-nucleotide polymorphisms β-adrenergic receptor β-blocker
DOI	10.3892/or.2018.6830
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5686899
专题	南华大学
作者单位	1.[Xie, Wan-Ying 2.Liu, Jie 3.He, Ruo-Hui 4.Li, Zhi 5.Tang, Yong-Jun 6.Wan, Zan 7.Mcleod, Howard L 8.He, Yi-Jing 9.Zhou, Cheng-Fang] Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
推荐引用方式 GB/T 7714	Xie, Wan-Ying,He, Ruo-Hui,Zhang, Jun,et al. betablockers inhibit the viability of breast cancer cells by regulating the ERK/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms.[J]. Oncology Reports,2019,41(1):341-350.
APA	Xie, Wan-Ying.,He, Ruo-Hui.,Zhang, Jun.,He, Yi-Jing.,Wan, Zan.,...&Liu, Jie.(2019).betablockers inhibit the viability of breast cancer cells by regulating the ERK/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms..Oncology Reports,41(1),341-350.
MLA	Xie, Wan-Ying,et al."betablockers inhibit the viability of breast cancer cells by regulating the ERK/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms.".Oncology Reports 41.1(2019):341-350.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。